Where to Find Wegovy in Stock: Steps to Take and the Shortage Status

Quick answer

As of September 2026, the FDA Drug Shortages database lists semaglutide injection, the active ingredient in Wegovy, with the status "Resolved," and the manufacturer's own site names 2 ways to fill a Wegovy prescription: a local pharmacy of your choice, or home delivery through NovoCare Pharmacy for patients paying cash. A "Resolved" status is a national statement about manufacturer supply, not a promise that the pharmacy nearest you has your prescribed presentation on the shelf today. If it does not, the fastest moves are to call before you drive, ask whether the pharmacy can order it, and, if it cannot, ask your prescriber to send the prescription to a pharmacy that has it.

Step 1: Call the pharmacy before you go

"Where can I find Wegovy in stock" and "is Wegovy in stock" are questions only a pharmacy can answer for its own shelf and its own orders, so the first call goes to the pharmacy that holds your prescription. Ask three things:

• Is the exact product on my prescription in stock right now (pen, syringe or tablet, and the strength my physician wrote)?
• If not, can you order it, and when would it arrive?
• If it cannot be ordered, can another pharmacy fill it, and will you release the prescription?

Wegovy is not one product. According to the FDA-approved label, Wegovy injection is supplied in cartons of single-dose pens, single-dose syringes with integrated needles, or a single-patient-use pen called Wegovy FlexTouch, and Wegovy is also supplied as a tablet. A pharmacy that is out of one presentation may have another, but only your prescriber can change what is written on the prescription. If you are unsure what yours says, see how to read a prescription label.

Step 2: Ask for a transfer or a new prescription

If the first pharmacy cannot fill, you have two paths, and the second is often faster.

Transfer. Prescription transfers between pharmacies are governed by state boards of pharmacy, and the wording differs by state. North Carolina's board, for example, tells its pharmacists: "Patients have the right to select their pharmacy provider. Patients have many reasons for choosing a particular pharmacy in the first instance or deciding that they wish to change to a different pharmacy. Whatever those reasons, the patient is the decision maker." In practice you call the pharmacy that has stock, give it the name and phone number of the pharmacy holding your prescription, and ask it to request the transfer. Ask both pharmacies how long that takes in your state.

New prescription. Ask your prescriber's office to send a fresh prescription to the pharmacy that confirmed stock, or to the manufacturer's mail channel. NovoCare's pharmacy page describes the second option this way: "Get your GLP-1 medicine shipped straight to you. Have your prescriber send your prescription to NovoCare Pharmacy and look for your confirmation text." Tell the office which pharmacy confirmed stock and for which presentation.

Step 3: Use the channels the manufacturer lists

The "How to get Wegovy" page on wegovy.com describes the fill step in one sentence: "You can fill your prescription at your local pharmacy. If you don't have insurance coverage and are paying cash for your prescription, you can fill it through the NovoCare Pharmacy and have it delivered right to your door." NovoCare's Wegovy page lays out the two options as "Home delivery: Get your medicine delivered directly to your door" and "Pharmacy pickup: Get your medicine sent to a local pharmacy of your choice for pickup," and it notes that CoAssist Pharmacy is the dispensing pharmacy for NovoCare Pharmacy.

One honest observation from reading those pages on September 19, 2026: they do not name any specific retail chain or online pharmacy as a stocking partner. Retail chains and online pharmacies that appear in a search for "wegovy in stock near me" are making their own availability claims, so treat an "in stock" banner as a prompt to call that seller, not as confirmation.

What if only my strength is out?

A single strength being unavailable is common and usually invisible in official data. The FDA's drug shortage FAQ says plainly: "Shortages that are expected to be resolved quickly, shortages that involve only a particular strength or package size, and shortages where a substitute strength(s) or package size(s) is available are not usually the focuses of FDA's program."

What to do instead:

• Ask the pharmacist whether the prescribed strength is available in a different presentation, for example a syringe instead of a pen, or a different pen type. The label lists several.
• Do not combine, split or substitute strengths on your own. A change in strength or dosage form is a prescribing decision, and your prescriber may want to see you before making it.
• If the gap will cause you to miss a scheduled dose, ask your prescriber what to do. The manufacturer's FAQ page carries missed-dose guidance for the injection, but your prescriber knows your history.

Does the Wegovy pill change availability?

The FDA-approved label now covers a tablet as well as the injection. The label states: "WEGOVY tablets are indicated in combination with a reduced calorie diet and increased physical activity" to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, and to reduce excess body weight and maintain weight reduction long term in adults with obesity, or in adults with overweight in the presence of at least one weight-related comorbid condition. The manufacturer's FAQ adds: "The Wegovy pill is FDA-approved and was reviewed by the FDA for effectiveness, safety, and quality. Wegovy has been available in pen form since 2021."

For a patient who cannot find the injection presentation they were prescribed, the tablet is a second dosage form their prescriber can consider. Whether it is appropriate is a prescribing decision, and the injection's label indications are broader in two respects: its weight indication also covers pediatric patients aged 12 years and older with obesity, and the injection carries a third indication, for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis in adults, which the tablet does not. Ask rather than assume.

Is there still a Wegovy shortage?

The FDA's database of "Current and Resolved Drug Shortages and Discontinuations Reported to FDA," read live on September 19, 2026, shows the entry "Semaglutide Injection" with "Status: Resolved." The record does not print a start or end date; its "Duration of Shortage" field reads "Prior to 2012 -" with nothing after the dash, and the FDA's FAQ explains that "Prior to 2012" appears when the original reporting date is unavailable.

The FDA defines the status it printed: "Resolved - A situation in which the market demand is covered and no supply issues are anticipated by the manufacturers." Separately, the openFDA drug shortages feed returned no semaglutide injection record at all that day, and the FAQ notes that "Resolved shortages remain on the list for 6 months and discontinued shortages remain on the list for 1 year." The record itself prints no resolution date, so this article does not state one.

What this means for you: the national supply question is answered, and your question is local. Stock varies by pharmacy, presentation and day, which is why the steps above begin with a phone call. For background on the drug class, see what a GLP-1 medication is.

Why was compounded semaglutide allowed during the shortage, and what changed when it ended?

Federal law draws a line between an FDA-approved drug and a compounded one, and the shortage list is written into that line. Section 503A of the Federal Food, Drug, and Cosmetic Act allows a licensed pharmacy to compound only if it "does not compound regularly or in inordinate amounts (as defined by the Secretary) any drug products that are essentially copies of a commercially available drug product." Section 503B, which covers outsourcing facilities, defines "essentially a copy of an approved drug" to include "a drug that is identical or nearly identical to an approved drug" and then carves out the shortage list: "unless, in the case of an approved drug, the drug appears on the drug shortage list in effect under section 356e of this title at the time of compounding, distribution, and dispensing."

That clause is the whole story. While semaglutide injection sat on the FDA shortage list, compounders could prepare versions of it under the conditions in the statute; the FDA's own compounding Q&A confirms that "Compounders also may prepare compounded versions of a drug on FDA's drug shortages list if the compounded drug meets certain conditions detailed in federal law." Once the record reads "Resolved," that shortage-based basis no longer exists, and the ordinary rule against compounding copies of a commercially available drug governs again.

What has not changed is the FDA's baseline position. Its GLP-1 page states: "A compounded drug might be appropriate if a patient's medical need cannot be met by an FDA-approved drug, or the FDA-approved drug is not commercially available. However, compounded drugs are not FDA approved." Compounded medications are not FDA-approved as final products. What that does and does not mean is covered in is compounded semaglutide FDA-approved.

How do I spot an unsafe "Wegovy in stock" offer online?

When the branded product is hard to find locally, "in stock" ads from unfamiliar websites multiply. The FDA's BeSafeRx program lists the warning signs of an unsafe online pharmacy, including one that "Does not require a doctor's prescription," one that "Is not licensed in the United States and by your state board of pharmacy," and one that "Offers deep discounts or prices that seem too good to be true." Its GLP-1 page adds telehealth red flags, such as a company that "does not require a screening and prescription by a licensed doctor before providing medicine" or that "makes spelling errors on the label or provides incorrect addresses of the pharmacy."

The FDA's general advice for this class of drugs is short: "Patients should obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy." BeSafeRx also links a tool to locate a state-licensed online pharmacy. This article names no seller and judges none. Read what a seller's own listing says about a prescription requirement, a physical U.S. address and a state license, and check the license with the state board.

Questions for your physician or pharmacist

• Which exact presentation is on my prescription, and is another presentation of the prescribed strength acceptable if that is what the pharmacy has?
• If my pharmacy cannot order it, will you send the prescription to a pharmacy that confirmed stock, or to NovoCare Pharmacy?
• If a stock gap makes me miss a scheduled dose, what should I do?
• Is the Wegovy tablet something you would consider for me, and why or why not?

Does price change where you can fill Wegovy?

Yes, because the manufacturer's self-pay offers run through specific channels, and the cash route wegovy.com names is NovoCare Pharmacy. Current list, self-pay and Medicare GLP-1 Bridge prices are covered in how much Wegovy costs and does Medicare cover Wegovy. If Wegovy stays out of reach, Wegovy alternatives explains the other FDA-approved options a physician may consider.

This article is for informational purposes only and does not constitute medical advice. Medication is prescribed only if a licensed physician determines it is appropriate. Sources were read on September 19, 2026; availability and pricing change.